Regentis Biomaterials Ltd. (RGNT) — Cash Flow-to-Debt Ratio
Regentis Biomaterials Ltd. (RGNT) has a Cash Flow-to-Debt Ratio of -0.48x as of December 2025, meaning its operating cash flow of $-1.38 Million could theoretically repay 0% of its total liabilities ($2.87 Million) in one year. For the full cash flow conversion analysis, see RGNT cash flow conversion.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regentis Biomaterials Ltd. Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Regentis Biomaterials Ltd. across 4 annual periods. See RGNT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Cash Flow-to-Debt Ratio for Regentis Biomaterials Ltd. (2022–2025)
Year-by-year debt coverage analysis for Regentis Biomaterials Ltd.. Check RGNT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.48x | $-1.38 Million | $2.87 Million | ▼ -3003.9% |
| 2024 | -0.02x | $-641.00K | $41.59 Million | ▲ +41.5% |
| 2023 | -0.03x | $-1.22 Million | $46.27 Million | ▲ +23.2% |
| 2022 | -0.03x | $-1.50 Million | $43.78 Million | — |